STACEY TEBBE: Open Payments
NPI 1073158119 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 45 payments from 13 companies in 2025. Trend: 2023 $2,484 · 2024 $2,031 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $188 |
| ABBVIE INC. | 9 | $175 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Novo Nordisk Inc | 4 | $80 |
| Lundbeck LLC | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| PFIZER INC. | 3 | $53 |
| Exact Sciences Corporation | 2 | $43 |
| Lilly USA, LLC | 2 | $35 |
| Amgen Inc. | 2 | $34 |
Products named: BREZTRI, REXULTI, UBRELVY, Wegovy, TRELEGY ELLIPTA, VRAYLAR, MOUNJARO, EVENITY.
Industry payments across IL — which companies pay providers there.
